Medicon Village reveals prolific investor panel line-up for its Medicon Village Investor Panel initiative
Medicon Village is proud to announce the members of its newly established Medicon Village Investor Panel (“MVIP”), an initiative designed to strengthen the financial ecosystem for life science companies by facilitating access to capital and strategic investor support.
The MVIP initiative, led by corporate finance expert Markus Neuding, aims to provide Medicon Village companies with a structured opportunity to present their businesses to a curated panel of experienced investors. Following the announcement of the concept earlier this year, Medicon Village now reveals the distinguished panel of investors who will participate in the first round of MVIP meetings scheduled for autumn 2025.
“I am extremely pleased to welcome such a highly qualified group of investors to MVIP,” says Markus Neuding. “Each panelist brings unique experience and a shared commitment to driving innovation in life sciences. This marks an important milestone in our ambition to strengthen the capital environment for Medicon Village companies and accelerate their growth journeys.”
By assembling a panel of seasoned investors with diverse backgrounds in life science funding, MVIP will not only offer access to capital but also unlock expertise, networks, and strategic guidance essential for scaling in this complex sector.
“What sets this initiative apart is its focus on helping life science companies take a long-term, strategic approach to fundraising. By engaging investors across multiple stages of capital and offering actionable feedback, MVIP will enable our companies to strengthen their competitiveness and become investment-ready at every stage of their growth journey,” says Sarah Lidé, Deputy CEO at Medicon Village Innovation.
MVIP Panelists:
- Bengt Julander, Linc
- Erika Henriksson, EQT
- Elin Almstedt, Navigare Ventures
- Hugo Mörse, Bonit Capital / Leksell Social
- Emanuel Stihl, Fåhraeus Startup & Growth
- Maria Tell, Segulah Medical Acceleration
- Lovisa Backemar, Eir Ventures
- Sebastian Hodel, Gainbridge Capital Partners
- Andreas Grape, Nordic Angels
- Ann-Charlotte Beckman, Life Science Invest
Markus Neuding, the initiator and permanent member of MVIP, will act as the convener of the panel. The panel will meet and evaluate selected life science companies and determine the best way to support them, financially, strategically, or through constructive feedback.
The first Medicon Village Investor Panel meeting is planned for autumn 2025. The application process for participating companies is available on Medicon Village’s webpage.